Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cancer/Tumor Profiling Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cancer tumor profiling market reached a value of US$ 9.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 18.22 Billion by 2027 exhibiting a growth rate (CAGR) of 11.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Cancer/tumor profiling, also known as biomarker testing, refers to a laboratory test or procedure used to identify specific proteins, genes or gene mutations (changes) and other biomarkers in a tumor tissue sample. It assists oncologists in determining if the pathways of a patient’s tumor match up with the available targeted therapies. It also aids in routine diagnostics, therapeutic decision-making, and developing personalized treatment plans and therapies for individuals based on the severity of their ailment and genomic build-up. Cancer/tumor profiling also finds extensive applications in personalized medicine, research, the discovery of biomarkers, and the development of screening and diagnostic techniques.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Cancer/Tumor Profiling Market Trends:

Cancer/tumor profiling is widely used in oncology research and discovery of biomarkers during the process of drug design, discovery and development. As a result, the widespread prevalence of cancer across the globe represents the primary factor driving the market growth. Besides this, the growing focus on biomarkers for diagnosis and tumor profiling and the shifting preferences toward personalized medicine among the masses are augmenting the product demand. Additionally, there has been a significant rise in government funding and support for cancer research for the development of advanced techniques to reduce the time taken for the detection and identification of tumors. Along with this, the recent advancements in molecular biology techniques, such as next-generation sequencing (NGS), are accelerating the adoption of cancer/tumor profiling. Furthermore, the increasing investments by pharmaceutical and biotechnology companies in research and development (R&D) activities for the launch of novel therapies and new drug designing techniques are propelling the market growth. Other factors, including the rising number of clinical trials, growing adoption of immunoassay techniques, favorable reimbursement policies, improving healthcare infrastructure, and technological advancements, are also creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cancer/tumor profiling market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on cancer type, technology, technique and application.

Breakup by Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Others
     

Breakup by Technology:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In-Situ Hybridization (ISH)
  • Microarray
  • Others
     

Breakup by Technique:

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics
     

Breakup by Application:

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Cancer Type, Technology, Technique, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG and Sysmex Corporation.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Cancer/Tumor Profiling Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Cancer Type
    6.1    Breast Cancer
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Lung Cancer
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Colorectal Cancer
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Prostate Cancer
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Melanoma Cancer
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Technology
    7.1    Next-Generation Sequencing (NGS)
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Polymerase Chain Reaction (PCR)
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Immunohistochemistry (IHC)
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    In-Situ Hybridization (ISH)
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Microarray
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Technique
    8.1    Genomics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Proteomics
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Epigenetics
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Metabolomics
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Application
    9.1    Personalized Medicine
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Diagnostics
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Biomarker Discovery
        9.3.1 Market Trends
        9.3.2 Market Forecast
    9.4    Prognostics
        9.4.1 Market Trends
        9.4.2 Market Forecast
    9.5    Others
        9.5.1 Market Trends
        9.5.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abbott Laboratories
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Becton Dickinson and Company
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials
           15.3.2.4 SWOT Analysis
        15.3.3    Caris Life Sciences
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Exact Sciences Corporation
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
           15.3.4.3 Financials
           15.3.4.4 SWOT Analysis
        15.3.5    F. Hoffmann-La Roche Ltd
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
           15.3.5.3 Financials
        15.3.6    Hologic Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
           15.3.6.3 Financials
           15.3.6.4 SWOT Analysis
        15.3.7    HTG Molecular Diagnostics Inc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials
        15.3.8    Illumina Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
           15.3.8.3 Financials
           15.3.8.4 SWOT Analysis
        15.3.9    Laboratory Corporation of America Holdings
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis
        15.3.10    NeoGenomics Laboratories
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio
           15.3.10.3 Financials
        15.3.11    Qiagen N.V.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio
           15.3.11.3 Financials
           15.3.11.4 SWOT Analysis
        15.3.12    Siemens AG
           15.3.12.1 Company Overview
           15.3.12.2 Product Portfolio
           15.3.12.3 Financials
           15.3.12.4 SWOT Analysis
        15.3.13    Sysmex Corporation
           15.3.13.1 Company Overview
           15.3.13.2 Product Portfolio
           15.3.13.3 Financials
           15.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Cancer/Tumor Profiling Market: Major Drivers and Challenges
Figure 2: Global: Cancer/Tumor Profiling Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer/Tumor Profiling Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cancer/Tumor Profiling Market: Breakup by Cancer Type (in %), 2021
Figure 5: Global: Cancer/Tumor Profiling Market: Breakup by Technology (in %), 2021
Figure 6: Global: Cancer/Tumor Profiling Market: Breakup by Technique (in %), 2021
Figure 7: Global: Cancer/Tumor Profiling Market: Breakup by Application (in %), 2021
Figure 8: Global: Cancer/Tumor Profiling Market: Breakup by Region (in %), 2021
Figure 9: Global: Cancer/Tumor Profiling (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Cancer/Tumor Profiling (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Cancer/Tumor Profiling (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Cancer/Tumor Profiling (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Cancer/Tumor Profiling (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Cancer/Tumor Profiling (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Cancer/Tumor Profiling (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Cancer/Tumor Profiling (Melanoma Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Cancer/Tumor Profiling (Other Cancer Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Cancer/Tumor Profiling (Other Cancer Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Cancer/Tumor Profiling (Next-Generation Sequencing-NGS) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Cancer/Tumor Profiling (Polymerase Chain Reaction-PCR) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Cancer/Tumor Profiling (Immunohistochemistry-IHC) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Cancer/Tumor Profiling (In-Situ Hybridization-ISH) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Cancer/Tumor Profiling (Microarray) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Cancer/Tumor Profiling (Microarray) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Cancer/Tumor Profiling (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Cancer/Tumor Profiling (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Cancer/Tumor Profiling (Genomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Cancer/Tumor Profiling (Genomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Cancer/Tumor Profiling (Proteomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Cancer/Tumor Profiling (Proteomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Cancer/Tumor Profiling (Epigenetics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Cancer/Tumor Profiling (Epigenetics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Cancer/Tumor Profiling (Metabolomics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Cancer/Tumor Profiling (Metabolomics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Cancer/Tumor Profiling (Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Cancer/Tumor Profiling (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Global: Cancer/Tumor Profiling (Diagnostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Global: Cancer/Tumor Profiling (Diagnostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Global: Cancer/Tumor Profiling (Biomarker Discovery) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Global: Cancer/Tumor Profiling (Prognostics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Global: Cancer/Tumor Profiling (Prognostics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Global: Cancer/Tumor Profiling (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Global: Cancer/Tumor Profiling (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: North America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: North America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: United States: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: United States: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Canada: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Canada: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Asia-Pacific: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Asia-Pacific: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: China: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: China: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Japan: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Japan: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: India: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: India: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: South Korea: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: South Korea: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Australia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Australia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: Indonesia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: Indonesia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Europe: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Europe: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Germany: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Germany: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: France: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: France: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: United Kingdom: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: United Kingdom: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Italy: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Italy: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Spain: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Spain: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Russia: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Russia: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Latin America: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Latin America: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Brazil: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 92: Brazil: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 93: Mexico: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 94: Mexico: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 95: Others: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 96: Others: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 97: Middle East and Africa: Cancer/Tumor Profiling Market: Sales Value (in Million US$), 2016 & 2021
Figure 98: Middle East and Africa: Cancer/Tumor Profiling Market: Breakup by Country (in %), 2021
Figure 99: Middle East and Africa: Cancer/Tumor Profiling Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 100: Global: Cancer/Tumor Profiling Industry: SWOT Analysis
Figure 101: Global: Cancer/Tumor Profiling Industry: Value Chain Analysis
Figure 102: Global: Cancer/Tumor Profiling Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cancer/Tumor Profiling Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Cancer Type (in Million US$), 2022-2027
Table 3: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technology (in Million US$), 2022-2027
Table 4: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Technique (in Million US$), 2022-2027
Table 5: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Cancer/Tumor Profiling Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 7: Global: Cancer/Tumor Profiling Market: Competitive Structure
Table 8: Global: Cancer/Tumor Profiling Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global cancer/tumor profiling market was valued at US$ 9.38 Billion in 2021.

We expect the global cancer/tumor profiling market to exhibit a CAGR of 11.20% during 2022-2027.

The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cancer/tumor profiling or biomarker testing procedures to reduce the risk of coronavirus infection upon hospital visits and interaction with healthcare professionals or medical equipment.

The rising prevalence of cancer, along with the increasing demand for cancer/tumor profiling in routine diagnostics, therapeutic decision-making, and developing personalized treatment plans and therapies for individuals, is primarily the global cancer/tumor profiling market.

Based on the cancer type, the global cancer/tumor profiling market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma cancer, and others. Among these, breast cancer currently holds the majority of the total market share.

Based on the technique, the global cancer/tumor profiling market can be divided into genomics, proteomics, epigenetics, and metabolomics. Currently, genomics exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global cancer/tumor profiling market include Abbott Laboratories, Becton Dickinson and Company, Caris Life Sciences, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Hologic Inc., HTG Molecular Diagnostics Inc., Illumina Inc., Laboratory Corporation of America Holdings, NeoGenomics Laboratories, Qiagen N.V., Siemens AG, and Sysmex Corporation.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links